Patents by Inventor Utane Matsukawa

Utane Matsukawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions for treating bone lesions in multiple myeloma
    Patent number: 6987100
    Abstract: Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both of an effect of suppressing bone resorption accompanying multiple myeloma and an effect of inhibiting multiple myeloma, more particularly, 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bisphosphonic acid or its salt.
    Type: Grant
    Filed: September 2, 2003
    Date of Patent: January 17, 2006
    Assignee: Astellas Pharm Inc.
    Inventors: Shohei Tanaka, Utane Matsukawa, Hironobu Asano
  • Medicinal compositions for treating osseous lesion in multiple myeloma
    Patent number: 6727233
    Abstract: Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both of an effect of suppressing bone resorption accompanying multiple myeloma and an effect of inhibiting multiple myeloma, more particularly, 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bisphosphonic acid or its salt.
    Type: Grant
    Filed: June 25, 2001
    Date of Patent: April 27, 2004
    Assignee: Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Shohei Tanaka, Utane Matsukawa, Hironobu Asano
  • Pharmaceutical compositions for treating bone lesions in multiple myeloma
    Publication number: 20040043966
    Abstract: Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both of an effect of suppressing bone resorption accompanying multiple myeloma and an effect of inhibiting multiple myeloma, more particularly, 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-l,l-bisphosphonic acid or its salt.
    Type: Application
    Filed: September 2, 2003
    Publication date: March 4, 2004
    Applicant: YAMANOUCHI PHARMACEUTICAL CO., LTD.
    Inventors: Shohei Tanaka, Utane Matsukawa, Hironobu Sano